$GHMBullishHigh

Graham Q4 Earnings Call Highlights

Graham (NYSE:GHM) reported Q4 gross profit of $15.3M (22.7% margin), down from 27% a year earlier, citing defense mix, lower aftermarket sales, and FlackTek purchase-accounting amortization. Q4 net income fell to $2.0M ($0.18/share) from $4.4M. Full-year gross profit rose 9% to $57.8M; margin declined to 23.5%. Backlog rose 29% to $533M. For FY2027, revenue guidance is $285M–$295M, gross margin 24.5%–25.5%, and adjusted EBITDA $35M–$40M.

9/10
9/10
High
Bullish
FY2027 guidance and margin/EBITDA ranges discussed on the Q4 earnings call (published today).
Supports a constructive read-through on defense/space demand and growth from FlackTek, with some margin pressure acknowledged.

Earnings call provides fresh margin drivers, backlog conversion expectations, and a detailed FY2027 outlook that can re-rate near-term growth and profitability.

Graham guided FY2027 revenue to $285M–$295M and EBITDA to $35M–$40M, citing record backlog and full-year FlackTek integration.

Bias toward upside if investors buy the margin recovery narrative (lower purchase accounting amortization, volume-driven improvement) and backlog conversion assumptions; downside risk if defense/space order timing volatility or tariff/material receipt impacts persist.

Background

Graham’s Q4 call covered margin pressure from defense mix and aftermarket weakness, plus FlackTek integration after its late-January acquisition and a $50M strategic investment post year-end.

Why it matters

The key trading inputs are the FY2027 revenue/gross margin/EBITDA ranges, backlog growth and expected conversion to revenue, and capital allocation (debt repayment plus growth initiatives) that shape forward valuation.

Market relevance

Fresh FY2027 guidance and backlog-to-revenue conversion expectations provide a direct basis for updating estimates and positioning around defense/space demand and margin trajectory.

Market effects

Reinforces demand strength in defense/space industrial equipment and the importance of mix (defense/material content) for margin modeling.

Highlights a new Navy facility in Batavia, NY and a manufacturing expansion in Arvada, CO, which may support regional capex/employment narratives.

Defense and space program production timelines can influence broader industrial supply chains, though the article is company-specific.

Alternative perspectives

Margin improvement is partly dependent on volume and a lower purchase-accounting amortization effect; if volume ramps slower or tariff/material receipt headwinds persist, guidance could prove optimistic.

Order volatility remains a risk (management cautioned on timing/size of contracts), and defense mix/material content drove margin compression—watch whether that mix normalizes into FY2027.

Key entities

  • Graham Corporation

    Industrial engineering firm reporting Q4 results, FlackTek/Xdot integration progress, and FY2027 guidance tied to defense and space demand.

  • FlackTek

    Advanced mixing/materials processing platform acquired end of January; management expects it to support FY2027 growth.

  • T. Rowe Price accounts

    Strategic $50M investment after year-end used partly for debt repayment and remainder for growth initiatives.

Related articles

$GHMMedAI 8/10

Graham Corporation (NYSE:GHM) Surprises With Q1 CY2026 Sales

Graham Corporation (NYSE: GHM) reported Q1 CY2026 sales of $67.08 million, up 13% year on year, exceeding market revenue expectations by 11.9%, according to the article. The company’s full-year revenue guidance of $290 million at the midpoint was 3% above analysts’ estimates. Non-GAAP EPS was $0.33, 10.9% above consensus, the article says.

$GHMMed

GRAHAM CORP (GHM): Results of Operations and Financial Condition

GRAHAM CORP (GHM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d79259dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 News Release Graham Corporation • 20 Florence Avenue • Batavia, NY 14020 IMMEDIATE RELEASE Graham Corporation Reports Fourth Quarter and Full-Year Fiscal 2026 Results • Record quarterly and full year revenue increased 13% to

$MSBMedAI 8/10

Mesoblast Shares Lead The ASX 200 Into The Weekend

Mesoblast (ASX: MSB) shares rose 6.67% to A$2.24 after the company reported fourth-quarter net revenue of US$36 million for the three months ended 30 June 2026, above market expectations. Full-year revenue was US$115 million, driven by stronger US uptake of its Ryoncil therapy in paediatric transplant patients.

$PEPMed

Americans cut back on PepsiCo drinks and snacks as gas prices rise

PepsiCo said Q2 net revenue rose 6.4% to $24.2B, beating FactSet’s $23.9B estimate, and net income more than doubled to $2.98B. However, North America demand weakened as consumers cut back amid higher gas prices, with snack volumes flat and beverage volumes down 4%. Overseas volumes rose 3% snacks and 2% beverages.